A major player in 340B drug discount reforms, Rep. Chris Collins (R-N.Y.) can’t serve on the House Energy & Commerce Committee, a key health committee, until federal charges of insider trading are resolved.
Collins booted from Energy & Commerce amid insider trading charges
